Changes in Hong Kong stocks | Fosun International (00656) closed up nearly 5%, and many of its companies performed well, and Fosun Pharmaceutical's non-net profit deducted in the first three quarters increased by more than 8%

The Zhitong Finance App learned that Fosun International (00656) closed up nearly 5%. At the close, it rose 4.74% to HK$4.64, with a turnover of HK$306.68,200.

According to the news, several listed companies under Fosun International recently announced their results. Fosun Pharmaceutical's revenue for the first three quarters was 30.463 billion yuan, up 3.64% year on year; net profit to mother was 2,667 billion yuan, up 5.71% year on year; net profit after deducting non-return to mother was 1,706 billion yuan, up 8.42% year on year. In addition, Yuyuan Co., Ltd., a subsidiary of Fosun International, had revenue of 22.981 billion yuan and net profit of 168 million yuan in the first three quarters; Fosun Hi-Tech's net profit for the first three quarters was 505 million yuan, turning a year-on-year loss into a profit.

CITIC Construction Investment previously released a research report saying that Fosun International Health Division, which includes many listed companies such as Fosun Pharmaceuticals, Fuhong Hanlin, and Furui Medical Technology, has achieved a tiered pipeline layout and is rich in research reserves; Happy Division has many high-quality assets and brands such as Yuyuan Mall, Laomiao Gold, Club Med, and Sanya Atlantis to continue to promote global development; and Fuzu Group holds Fosun Portugal Insurance, Dingrui Reinsurance, HAL, and BFC to continue to expand steadily. The company will continue to advance the 8424 strategy in 2026 under the plan of “focusing on the main business, slimming down and fitness”.